To meet the urgent need to expand laboratory capacity, the Centers for Medicare & Medicaid Services yesterday announced a relaxed enforcement policy under the Clinical Laboratory Improvement Amendments during the COVID-19 public health emergency with respect to review of pathology slides, proficiency testing, alternate collection devices, and requirements for a CLIA certificate. Among other flexibilities, CMS said the policy will enable:

  • Pathologists to review pathology slides remotely if certain defined conditions are met;

  • U.S. laboratories performing COVID-19 testing that apply for CLIA certification to begin testing as quickly as possible; and

  • Laboratories within a hospital/university hospital campus to hold a single CLIA certificate for the laboratory sites within the same physical location or street address

Related News Articles

Blog
The American Hospital Association and its Society for Healthcare Strategy and Market Development (SHSMD) July 15 hosted “Addressing COVID-19 Vaccine Hesitancy…
Headline
Read a recap and insights from health care leaders during AHA’s July 15 webinar, “Addressing COVID-19 Vaccine Hesitancy in Your Community,” featuring messaging…
Headline
Three-quarters of the 469 COVID-19 cases associated with summer events and large public gatherings this month in Barnstable County, Mass., were in people fully…
Headline
About 8.9 million children aged 12-17 have received the Pfizer COVID-19 vaccine, the Centers for Disease Control and Prevention reported today. Based on data…
Headline
AHA today joined 27 other organizations that serve the mental, emotional and behavioral health of children in urging Congress to strengthen the pediatric…
Perspective
The COVID-19 Provider Relief Fund has been a lifeline for hospitals, health systems and health care providers, allowing them to continue to put the health and…